Single dose azithromycin

Details Single dose azithromycin Single dose azithromycin

2006-01-17

2006-01-17

Wilson, James O. (Department: 1623)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Carbohydrate doai

Reexamination Certificate

active

06987093

ABSTRACT:
The present invention relates to a method of treating a bacterial respiratory or acute otitis media infections in humans by administering a single dose of azithromycin wherein the dose is about 40 mg/kg body weight or greater.

REFERENCES:
patent: 4328334 (1982-05-01), Kobrehel et al.
patent: 4474768 (1984-10-01), Bright
patent: 4517359 (1985-05-01), Kobrehel et al.
patent: 4963531 (1990-10-01), Remington
patent: 5498699 (1996-03-01), Djokic et al.
patent: 5605889 (1997-02-01), Curatolo et al.
patent: 5633006 (1997-05-01), Catania et al.
patent: 5686587 (1997-11-01), Yang
patent: 6068859 (2000-05-01), Curatolo et al.
patent: 6110965 (2000-08-01), Lazarevski et al.
patent: 6268489 (2001-07-01), Allen et al.
patent: 6569443 (2003-05-01), Dawson et al.
patent: 2004/0053264 (2004-03-01), Park
Block et al., “Single Dose Azithromycin (30 mg/kg) in Acute Otitis Media”, 38thannual meeting of the Infectious Disease Society of america, New Orleans, La., Sep. 7-10, 2000.
P/S/L Consulting Group, Inc., “Single-Dose Zithromax (azithromycin) as effective as 10 days of Augmentin (Amozcillin/Clavulenate) for Otitis Media”, Doctor's, Guide; Sep. 14, 2000.
Law et al., “Single-Dose Azithromycin for Respiratory Tract Infections”, The Annals of Pharmacotherapy, vol. 38, pp 433-439, Mar. 2004.
Arguedas, A., Single-Dose Therapy in Otitis Media, Poster Presentation at 9thEuropean Congress of Clinical Microbiology and Infectious Diseases, Berlin, Germany, Mar. 21-24, 1999,Clin. Microbiol. Infect. 1999:5 (Supp. Mar. 3):28 (Abstr).
S. Block et al., Single-Dose Azithromycin (30 mg/kg) in Acute Otitis Media, 38thAnnual Meeting of the Infectious Disease Society of America, New Orleans, LA, Sep. 7-10, 2000 (Abstract 174).
P/S/L Consulting Group Inc., Single-Dose Zithromax (Azithromycin) as Effective as 10 Days of Augmentin (Amoxcillin/Clavulenate) for Otitis Media, Doctor's Guide; Sep. 14, 2000.
FDA Briefing Package: Zithromax® (Azithromycin) Oral Suspension Single-Dose and Three Day Treatment of Acute Otitis Media, Anti-Infective Drugs Advisory Committee, Nov. 7, 2001.
Schonwald, S., et al., Infection, Germany, vol. 27, No. 3, May 1999, pp. 198-202 XP008018295.
Amsden, G.W., et al., The J. of Antimicrobial Chemotherapy, 47(1), pp. 61-66 (2001) XP001159703.
Mulier O., The J. of Antimicrobial Chemotherapy, England, Jun. 1993, vol. 31, suppl. E, Jun. 1993, pp. 137-146 XP008018300.
Nightingale C.H., et al., J. of Infectious Disease Pharmacotherapy 1999, vol. 4, No. 1, pp. 17-24 XP008018297.
Aoki N., Japanese Journal of Chemotherapy 1995, Japan, vol. 43, No. Suppl 6, pp. 234-238 XP008018296.
Morris, D.L., et al., vol. 10, No. 10., Oct. 1991, pp. 859-861, European J. of Clinical Microbiology & Infectious Disease: Official Publication of the European Society of Clinical Microbiology, Germany XP008018299.
Klepser, M., et al., International J. of Antimicrobial Agents, vol. 17, No. Supp 1, Jun. 2001, p. S157, 22nd International Congress of Chemotherapy; Amsterdam, Jun. 30-Jul. 3, 2001 XP002244592.
Bergogne-Berezin Eugenie, Pathologie Biologie, vol. 43, No. 6, 1995, pp. 498-504, “Azithromycin: Tissue pharmacokinetic data” XP008018308.

Affiliated with

Also associated with

Rating

Single dose azithromycin does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Single dose azithromycin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Single dose azithromycin will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3585062